Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 13, Number 9—September 2007

Letter

Disseminated Bocavirus Infection after Stem Cell Transplant

Thomas Schenk*, Brigitte Strahm*, Udo Kontny*, Markus Hufnagel*, Dieter Neumann-Haefelin*, and Valeria Falcone*Comments to Author 
Author affiliations: *Freiburg University Medical Center, Freiburg, Germany;

Main Article

Appendix Figure

Timeline of clinical and virologic features posttransplantation. A) Main clinical events and therapeutic measures. B) Human bocavirus (HBoV) DNA load measured by real-time PCR; 1 mL stool suspension corresponds to 20 mg starting material. Nasopharyngeal samples (NPS) also positive for rhinovirus (RV) RNA by multiplex PCR are indicated by arrows. C) Copies of cytomegalovirus (CMV) DNA measured in blood by real-time PCR. NPSC3.1 plasmid (positive control for PCR) was provided by T. Allender.

Appendix Figure. Timeline of clinical and virologic features posttransplantation. A) Main clinical events and therapeutic measures. B) Human bocavirus (HBoV) DNA load measured by real-time PCR; 1 mL stool suspension corresponds to 20 mg starting material. Nasopharyngeal samples (NPS) also positive for rhinovirus (RV) RNA by multiplex PCR are indicated by arrows. C) Copies of cytomegalovirus (CMV) DNA measured in blood by real-time PCR. NPSC3.1 plasmid (positive control for PCR) was provided by T. Allender.

Main Article

TOP